Authors: Louise Walker, Research Communications Officer, Alzheimer’s Society
Compared to 2016, the year 2017 has been quieter on the ‘big news’ front, with few trials announcing results. However, it has been a great year for seeing promising projects moving forwards and for researchers really digging deep into the causes of Alzheimer’s.
AAIC comes to London
Probably the biggest event of this year for us was the Alzheimer’s Association International Conference (AAIC), which came to the Excel centre in London in July (16–20). This conference is always an exciting time for dementia research and it was great to have it on our doorstep! Whilst this year’s conference didn’t really cover any big trial results, we were treated to lots of interesting findings and discussions. A key theme was biomarkers, and it was particularly encouraging to see progress being made on the development of PET scans for amyloid and tau, the two key proteins associated with Alzheimer’s disease (AD).
Looking towards prevention, delegates were able to hear first-hand about the international rollout of the FINGER study, which aims to see if a multidomain intervention including diet, exercise and cognitive training can reduce dementia risk. FINGER is the most promising intervention study into risk reduction to date and Miia Kivipelto discussed ambitious plans to find out whether the intervention can be adopted by other countries, including the US, Europe, Australia and Singapore.